Publications of Ilona Behrendt

Gränicher, G.; Tapia, F.; Behrendt, I.; Jordan, I.; Genzel, Y.; Reichl, U.: Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal 16 (1), e2000024 (2021)

Coronel, J.; Behrendt, I.; Bürgin, T.; Anderlei, T.; Sandig, V.; Reichl, U.; Genzel, Y.: Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems. Vaccine 37 (47), pp. 7011 - 7018 (2019)

Genzel, Y.; Vogel, T.; Buck, J.; Behrendt, I.; Vazquez-Ramirez, D.; Schiedner, G.; Jordan, I.; Reichl, U.: High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells. Vaccine 32 (24), pp. 2770 - 2781 (2014)

Tapia, F.; Vogel, T.; Genzel, Y.; Behrendt, I.; Hirschel, M.; Gangemi, J. D.; Reichl, U.: Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine 32 (8), pp. 1003 - 1011 (2014)

Frensing, T.; Heldt, S.; Pflugmacher, A.; Behrendt, I.; Jordan, I.; Flockerzi, D.; Genzel, Y.; Reichl, U.: Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles. PLoS One 8 (9), e72288 (2013)

Genzel, Y.; Behrendt, I.; Rödig, J.; Rapp, E.; Kueppers, C.; Kochanek, S.; Schiedner, G.; Reichl, U.: CAP, a new human suspension cell line for influenza virus production. Applied Microbiology and Biotechnology 97 (1), pp. 111 - 122 (2013)

Lohr, V.; Genzel, Y.; Behrendt, I.; Scharfenberg, K.; Reichl, U.: A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine 28 (38), pp. 6256 - 6264 (2010)

Genzel, Y.; Behrendt, I.; König, S.; Sann, H.; Reichl, U.: Metabolism of MDCK Cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 22, pp. 2202 - 2208 (2004)

Göbel, S.; Pelz, L.; Behrendt, I.; Prömmel, M.; Altomonte, J.; Anderlei, T.; Bürgin, T.; Genzel, Y.; Reichl, U.: Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. In Proceedings Single-Use Technologies V: Building the Future, 40. Single-Use Technologies V: Building the Future, Marseille, France, March 20, 2022 - March 23, 2022. (2022)

Zinnecker, T. M.; Behrendt, I.; Lau, M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. In Proceedings Vaccine Technology VIII, 55. Vaccine Technology VIII, Sitges (Spain), June 12, 2022 - June 17, 2022. (2022)

Coronel, J.; Genzel, Y.; Reichl, U.; Behrendt, I.; Buergin, T.; Andereli, T.; Sandig, V.: Orbital shaken bioreactor for influenza A virus production in high cell density cultivations. In Vaccine Technology VII, 40. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)

Göbel, S.; Pelz, L.; Behrendt, I.; Prömmel, M.; Altomonte, J.; Anderlei, T.; Bürgin, T.; Genzel, Y.; Reichl, U.: Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. Single-Use Technologies V: Building the Future, Marseille, France (2022)

Zinnecker, T. M.; Behrendt, I.; Lau , M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. Vaccine Technology VIII, Sitges (Spain) (2022)

Vazquez-Ramirez, D.; Nikolay, A.; Behrendt, I.; Jordan, I.; Bürgin, T.; Genzel, Y.; Reichl, U.: High-cell-density cultivations by hollow fiber-based perfusion for intensified viral vaccine production. VII SLATCC meeting , Cocoyoc, Morelos, Mexico (2016)

Genzel, Y.; Behrendt, I.; Vogel, T.; Jordan, I.; Reichl, U.: Perfusion über das ATF System: Influenza Virusproduktion in Hochzelldichte. GVC/DECHEMA: Effiziente Verfahren und Anlagen in der Bioverfahrenstechnik und Lebensmittelbiotechnologie, Bad Wildungen, Germany (2013)

Genzel, Y.; Lohr, V.; Behrendt, I.; Scharfenberg, K.; Kamen, A.; Schiedner, G.; Jordan, I.; Reichl, U.: Cell culture-based influenza virus production: suspension or adherent producer cell lines? Cell line development and engineering 2012, Cologne, Germany (2012)

Genzel, Y.; Vogel, T.; Buck, J.; Behrendt, I.; Schiedner, G.; Jordan, I.; Reichl, U.: High cell density cultivations for influenza virus production using suspension cells. Vaccine Technology IV, Albufeira, Portugal (2012)

Genzel, Y.; Janke, R.; Isken, B.; Rödig, J.; Rapp, E.; Lohr, V.; Behrendt, I.; Scharfenberg, K.; Kamen, A.; Schiedner, G. et al.; Jordan, I.; Reichl, U.: Influenza virus production: characteristics of different producer cell lines. 10th PEACe 2011, Cascais, Portugal (2011)

Zinnecker, T. M.; Behrendt, I.; Lau , M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. Vaccine Technology VIII, Sitges (Spain) (2022)

Zinnecker, T. M.; Behrendt, I.; Lau, M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Suspension MDCK cell line development by automated single-cell cloning & scale-down into ambr^®15 microbioreactors in chemically defined medium. 27th ESACT Meeting, Lisbon (Portugal) (2022)